Stocks › BHVN
Biohaven BHVN
US equityMarket cap rank #2714
$12.39 −$1.26 (-9.23%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.51 +0.97%
Open$13.26
Prev close$13.65
Day range$12.31 – $13.75
Volume2.39M
Market cap$1.87B
P/E (TTM)–
Dividend yield–
BHVN Stock News
Headlines matching Biohaven or the BHVN ticker, most recent first.
- RBC Capital Downgrades Biohaven(BHVN.US) to Hold Rating, Cuts Target Price to $19 Negative
- CCORF Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $21
- Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)
- Citi Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $17
- Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Boston Scientific (BSX) Positive
- J.P. Morgan Maintains Biohaven(BHVN.US) With Buy Rating
- Raymond James Maintains Biohaven(BHVN.US) With Buy Rating
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN)
- William Blair Maintains Biohaven(BHVN.US) With Hold Rating
- Analysts Are Bullish on These Healthcare Stocks: Globus Medical (GMED), Biohaven Ltd. (BHVN) Positive
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)
- BofA Securities Maintains Biohaven(BHVN.US) With Sell Rating, Maintains Target Price $11
- Analysts' Top Healthcare Picks: Molina Healthcare (MOH), Biohaven Ltd. (BHVN)
- Raymond James Maintains Biohaven(BHVN.US) With Buy Rating, Announces Target Price $30
- Piper Sandler Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $30
No comments yet — be the first to weigh in on BHVN.
Sign in to join the discussion.